Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
INMD | US
0.34
2.20%
Healthcare
Medical Devices
30/06/2024
04/10/2024
15.78
15.37
15.80
15.37
InMode Ltd. designs develops manufactures and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures such as liposuction with simultaneous skin tightening body and face contouring and ablative skin rejuvenation treatments as well as for use in women's health conditions and procedures. It also designs develops manufactures and markets non-invasive medical aesthetic products that target an array of procedures including permanent hair reduction facial skin rejuvenation wrinkle reduction cellulite treatment skin appearance and texture and superficial benign vascular and pigmented lesions as well as hands-free medical aesthetic products that target a range of procedures such as skin tightening fat reduction and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam Israel.
View LessValue Stock (Price to Book < 3)
Price Below SMA10D
High Short-term Volatility
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.0%1 month
54.0%3 months
50.7%6 months
44.0%10.08
8.64
1.77
-
-
4.50
1.45
2.90
134.65M
1.20B
1.20B
-
21.18
-56.90
-36.50
21.05
7.32
10.20
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.60
Range1M
3.05
Range3M
4.42
Rel. volume
0.96
Price X volume
18.57M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Integra LifeSciences Holdings Corporation | IART | Medical Devices | 17 | 1.32B | -1.85% | 61.62 | 130.98% |
Establishment Labs Holdings Inc | ESTA | Medical Devices | 45.25 | 1.26B | 1.32% | n/a | 438.84% |
BioLife Solutions Inc | BLFS | Medical Instruments & Supplies | 24.54 | 1.13B | 1.03% | n/a | 11.19% |
ARTIVION INC | AORT | Medical Devices | 26.44 | 1.11B | 0.34% | n/a | 122.90% |
Pulse Biosciences Inc | PLSE | Medical Instruments & Supplies | 15.98 | 979.42M | -3.33% | n/a | 32.05% |
Perspective Therapeutics Inc. | CATX | Medical Devices | 13.35 | 900.16M | 1.06% | n/a | 0.00% |
MiMedx Group Inc | MDXG | Medical Devices | 5.76 | 845.62M | -0.69% | 10.23 | 11.46% |
Embecta Corp | EMBC | Medical Instruments & Supplies | 13.51 | 779.55M | -3.08% | 11.80 | -216.41% |
Alphatec Holdings Inc | ATEC | Medical Instruments & Supplies | 5.49 | 771.13M | 4.57% | n/a | 1364.44% |
Bioventus Inc. | BVS | Medical Devices | 11.75 | 765.95M | -0.25% | n/a | 261.56% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pitney Bowes Inc | PBI | Building Products & Equipment | 6.92 | 1.24B | 1.91% | n/a | -571.93% |
ARLO TECHNOLOGIES INC | ARLO | Building Products & Equipment | 11.47 | 1.15B | 0.09% | n/a | 19.46% |
The Real Brokerage Inc. Common Shares | REAX | Real Estate Services | 5.75 | 1.12B | 1.23% | n/a | 0.00% |
Latham Group Inc. | SWIM | Building Products & Equipment | 6.64 | 767.43M | 0.00% | 61.27 | 77.00% |
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
FRP Holdings Inc | FRPH | Real Estate Services | 30.13 | 573.39M | 2.27% | 74.92 | 42.65% |
HOUS | HOUS | Real Estate Services | 5.03 | 559.70M | -5.27% | n/a | 201.36% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
The RMR Group Inc | RMR | Real Estate Services | 25.49 | 426.32M | 1.27% | 16.38 | 14.14% |
RE/MAX Holdings Inc | RMAX | Real Estate Services | 11.85 | 372.29M | -4.67% | n/a | 114.28% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 4.50 | 45.99 | Cheaper |
Ent. to Revenue | 1.45 | 13.20 | Cheaper |
PE Ratio | 10.08 | 29.98 | Cheaper |
Price to Book | 1.77 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 50.69 | 66.08 | Lower Risk |
Debt to Equity | - | 0.83 | - |
Debt to Assets | - | 0.28 | - |
Market Cap | 1.20B | 9.42B | Emerging |